Sort
261,768 grants matching “gene therapy”
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,500,000Mani Subramanian · Mitopower Llc · U44 · FY2023 · AA
Treatment of GM1 gangliosidosis CNS manifestations by AAV systemic expression of lectin-enhanced enzyme
$1,500,000Walter Acosta · Biostrategies, Lc · R44 · FY2025 · NS
Diabetes Genome Anatomy Project (DGAP)
$1,500,000Joslin Diabetes Center · R01 · FY2003 · DK
Targeting Cell Signaling in lung cancer to enhance therapeutic efficacy
$1,500,000Fadlo Raja Khuri · Emory University · P01 · FY2006 · CA
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2009 · CA
Center for Synthetic Regulatory Genomics
$1,500,000Jef D Boeke · New York University School Of Medicine · RM1 · FY2019 · HG
DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA
$1,500,000Randall J Bateman · Washington University · U01 · FY2014 · AG
SLE Treatment with N-acetylcysteine
$1,500,000Andras Perl · Upstate Medical University · U01 · FY2020 · AR
DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA
$1,500,000Randall J Bateman · Washington University · U01 · FY2016 · AG
Creatine Safety, Tolerability, and Efficacy in Huntington's Disease: CREST-E
$1,500,000Steven M Hersch · Massachusetts General Hospital · U01 · FY2014 · AT
Baylor College of Medicine Cancer Center
$1,500,000C Kent Osborne · Baylor College Of Medicine · P30 · FY2007 · CA
In Vivo Cellular and Molecular Imaging Centers (ICMICs)
$1,500,000Robert F Mattrey · University Of California, San Diego · P50 · FY2010 · CA
IGF::OT::IGF RADIOPROTECTOR FOR HEAD AND NECK CANCERPERIOD OF PERFORMANCE: 05/09/2016 - 05/08/2018
$1,500,000James Crapo · Biomimetix Jv, Llc · N43 · FY2016 · CA
CENTER FOR AIDS RESEARCH(CFAR)
$1,500,000Case Western Reserve University · P30 · FY2004 · AI
NHLBI GTRP Clinical Coordinating Center
$1,500,000Susan Sepelak · Social And Scientific Systems, Inc. · N01 · FY2010 · HL
Biomarkers for Therapy of FSHD (U54)
$1,500,000Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · U54 · FY2013 · HD
Gene Therapy that Systemically Produces Brain-penetrating Replacement Enzyme for MPS IIIA (Sanfilippo A Syndrome)
$1,500,000Shivakumar Devaiah Pattada · Biostrategies, Lc · R44 · FY2023 · NS
Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder
$1,500,000Boris Tabakoff · Lohocla Research Corporation · U44 · FY2019 · AA
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2008 · CA
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,500,000Mani Subramanian · Mitopower Llc · U44 · FY2024 · AA
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders
$1,500,000Henryk Dudek · Dicerna Pharmaceuticals, Inc. · U44 · FY2021 · AA
Development of an ALDH2-Targeting RNAi Therapeutic for Alcohol Use Disorders
$1,500,000Henryk Dudek · Dicerna Pharmaceuticals, Inc. · U44 · FY2020 · AA
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,499,999Mani Subramanian · Mitopower Llc · U44 · FY2025 · AA
Metabolomic and Genetic Factors Decoupling Immune Checkpoint Inhibitor Tumor Efficacy and Cardiovascular Toxicity
$1,499,996Nicolas Palaskas · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · FD
Center of Research Translation in Muscular Dystrophy Therapeutic Development
$1,499,955Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · P50 · FY2016 · AR